It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Antimicrobial resistance is a serious threat to global public health, but little is known about the effects of microbial control on the microbiota and its associated resistome. Here we compare the microbiota present on surfaces of clinical settings with other built environments. Using state-of-the-art metagenomics approaches and genome and plasmid reconstruction, we show that increased confinement and cleaning is associated with a loss of microbial diversity and a shift from Gram-positive bacteria, such as Actinobacteria and Firmicutes, to Gram-negative such as Proteobacteria. Moreover, the microbiome of highly maintained built environments has a different resistome when compared to other built environments, as well as a higher diversity in resistance genes. Our results highlight that the loss of microbial diversity correlates with an increase in resistance, and the need for implementing strategies to restore bacterial diversity in certain built environments.
The environmental microbiota can have important implications for our well-being. Here, the authors describe the composition of microbiomes from diverse buildings, including samples from clinical environments, and show that cleaner environments are associated with a loss of microbial diversity and an increase in genes associated with antibiotic resistance.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details


1 Graz University of Technology, Institute of Environmental Biotechnology, Graz, Austria (GRID:grid.410413.3) (ISNI:0000 0001 2294 748X)
2 Medical University Graz, Department of Internal Medicine, Graz, Austria (GRID:grid.11598.34) (ISNI:0000 0000 8988 2476); BioTechMed Graz, Graz, Austria (GRID:grid.452216.6)
3 University of Vienna, Division of Computational Systems Biology, Department of Microbiology and Ecosystem Science, Vienna, Austria (GRID:grid.10420.37) (ISNI:0000 0001 2286 1424)
4 Ben-Gurion University of the Negev, Department of Life Sciences, Faculty of Natural Sciences, Beer-Sheva, Israel (GRID:grid.7489.2) (ISNI:0000 0004 1937 0511)
5 Centro Nacional de Biotecnologia, CSIC, Madrid, Spain (GRID:grid.428469.5) (ISNI:0000 0004 1794 1018)
6 Graz University of Technology, Institute of Environmental Biotechnology, Graz, Austria (GRID:grid.410413.3) (ISNI:0000 0001 2294 748X); BioTechMed Graz, Graz, Austria (GRID:grid.452216.6)